News and Announcements
Analytica Receive FDA Approval for Over the Counter Clearance PeriCoach
- Published July 13, 2016 10:32AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
12th July 2016, ASX Announcement
Analytica Ltd (ASX: ALT) is pleased to announce that the US Food and Drug Administration (FDA) has granted the company over-the-counter (OTC) clearance for the PeriCoach system, previously available in the US by prescription only.
The PeriCoach is a unique medical device that assists women to exercise their pelvic floor muscles in order to reduce or eliminate Stress Urinary Incontinence, a condition that affects 1 in 3 women.
“Women can use pelvic floor exercises or “Kegels” to reduce or eliminate urinary incontinence symptoms, and with PeriCoach now available over the counter, home training just got a lot more convenient,” said Leslie Rickey, MPH, MD, Associate Professor of Urology and of Obstetrics, Gynaecology and Reproductive Sciences and Fellowship Director of Female Pelvic Medicine and Reconstructive Surgery, Yale School of Medicine.
To view the full announcement, please click on the button below.